Lower education linked to premature death from malignant skin melanoma

April 16, 2013

There are socioeconomic differences in Sweden in survival amongst people with malignant skin melanoma, according to a new study published in the European Journal of Cancer. Melanoma patients with a lower educational background are much more likely to die of the disease.

Cutaneous malignant melanoma is the most aggressive form of , and one of the most rapidly increasing cancers among western populations. In response to this worsening health problem a team of researchers at Karolinska Institutet and Lindköping University amongst others, have accessed unique data from the Swedish Melanoma Register for examining the link between prognosis and socio-economic status in a large population-based study more closely.

Skin melanoma can be cured if the tumour is removed before the have had time to spread to other parts of the body. The long-term survival rate for early-detected thin skin melanoma in Sweden is over 90 per cent. However, the prognosis for patients whose melanoma has already spread at the time of discovery is much worse. Early detection is therefore essential to a good prognosis.

The present study is based on all cases of invasive cutaneous malignant melanoma diagnosed in Sweden between 1990 and 2007. The researchers studied the survival statistics for over 27,000 melanoma patients relative to the point at which they left formal education (basic school, upper secondary, or tertiary), controlling for factors already known to affect prognosis (e.g. tumour properties, sex of patient and location of tumour).

"Our results show that patients diagnosed with cutaneous melanoma with a lower level of formal education have a more advanced disease at the time of diagnosis and thus a lower chance of survival", says Dr Hanna Eriksson, Doctoral Student at Karolinska Institutets Department of Oncology-Pathology and lead author of the paper in which the results are presented. " can be improved if we can reach these people with so that the melanoma can be detected in time."

The researchers write that apart from the fact that people with a lower level of education tended to have later-stage melanoma when diagnosed, lifestyle factors and differences in access to healthcare may impact on this correlation between education level and prognosis.

"The relative effect of educational level on the risk of death from the disease was greater for example the women and younger individuals we looked at", says Dr Eriksson. "All in all, however, the men had worse prognoses than the women."

While previous research has shown that high socioeconomic status increases the risk of developing malignant skin , the present study indicates that a lower level of is linked to a reduced survival from the disease in Sweden, where the aim of the healthcare services is to reach to the entire population.

Explore further: Smaller surgical procedure sufficient for high-risk melanoma

More information: Eriksson, H. et al. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden, European Journal of Cancer, 11 April 2013. doi:10.1016/j.ejca.2013.03.013

Related Stories

Smaller surgical procedure sufficient for high-risk melanoma

October 25, 2011
(Medical Xpress) -- A smaller surgical procedure is fully sufficient to treat patients with the more hazardous form of malignant melanoma of the skin. This according to a major international multicentre study, coordinated ...

Risk of second primary melanoma up in pediatric patients

June 28, 2012
(HealthDay) -- Pediatric patients diagnosed with an invasive cutaneous melanoma have nearly double the relative risk of developing a subsequent primary melanoma, compared with adults, according to a study published online ...

Gene identified in some melanoma linked to increased resistance to treatment

February 19, 2013
(Medical Xpress)—Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research published today in ...

Melanoma up to 2.5 times likelier to strike transplant, lymphoma patients

October 3, 2012
Melanoma is on the rise nationally, and transplant recipients and lymphoma patients are far likelier than the average person to get that form of skin cancer and to die from it, a Mayo Clinic review has found. That is because ...

Aspirin may lower melanoma risk

March 11, 2013
A new study has found that women who take aspirin have a reduced risk of developing melanoma—and that the longer they take it, the lower the risk. The findings suggest that aspirin's anti-inflammatory effects may help protect ...

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.